These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3954864)

  • 1. The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components.
    Becker JB; Beer ME
    Behav Brain Res; 1986 Jan; 19(1):27-33. PubMed ID: 3954864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release.
    Becker JB
    Synapse; 1990; 5(2):157-64. PubMed ID: 2309159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis.
    Becker JB
    Neurosci Lett; 1990 Oct; 118(2):169-71. PubMed ID: 2125712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis.
    Becker JB; Cha JH
    Behav Brain Res; 1989 Nov; 35(2):117-25. PubMed ID: 2818831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17β-Estradiol infusions into the dorsal striatum rapidly increase dorsal striatal dopamine release in vivo.
    Shams WM; Sanio C; Quinlan MG; Brake WG
    Neuroscience; 2016 Aug; 330():162-70. PubMed ID: 27256507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sex and estrogen on behavioral sensitization to cocaine in rats.
    Hu M; Becker JB
    J Neurosci; 2003 Jan; 23(2):693-9. PubMed ID: 12533629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats.
    Yu PL; Wu CI; Lee TS; Pan WH; Wang PS; Wang SW
    J Cell Biochem; 2009 Dec; 108(6):1318-24. PubMed ID: 19830701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study.
    Becker JB; Rudick CN
    Pharmacol Biochem Behav; 1999 Sep; 64(1):53-7. PubMed ID: 10494997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ovariectomy and estrogen replacement on intrastriatal dopamine-elicited postural deviation.
    Smith RL; Van Hartesveldt C
    Pharmacol Biochem Behav; 1985 May; 22(5):689-93. PubMed ID: 4011632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
    Quesada A; Micevych PE
    J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences.
    Robinson TE; Becker JB; Presty SK
    Brain Res; 1982 Dec; 253(1-2):231-41. PubMed ID: 6891283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats.
    Ohtani H; Nomoto M; Douchi T
    Brain Res; 2001 May; 900(2):163-8. PubMed ID: 11334794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro.
    Becker JB; Ramirez VD
    Brain Res; 1981 Jan; 204(2):361-72. PubMed ID: 7193066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release.
    Xiao L; Becker JB
    Synapse; 1998 Aug; 29(4):379-91. PubMed ID: 9661256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.
    Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C
    J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R
    Brain Res; 1979 Mar; 164():217-25. PubMed ID: 154937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effects of progesterone upon dopamine release from the corpus striatum of ovariectomized estrogen-treated rats are stereo-specific.
    Dluzen DE; Ramirez VD
    Brain Res; 1991 Jan; 538(1):176-9. PubMed ID: 2018930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
    Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.